• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾癌的预后因素。手术所见的评估。

Prognostic factors in renal carcinoma. An evaluation of operative findings.

作者信息

Nurmi M J

出版信息

Br J Urol. 1984 Jun;56(3):270-5. doi: 10.1111/j.1464-410x.1984.tb05385.x.

DOI:10.1111/j.1464-410x.1984.tb05385.x
PMID:6544609
Abstract

A consecutive series of 257 patients with renal carcinoma treated by radical nephrectomy is presented. The crude 5-year and 10-year survival rates for all patients were 47 and 31% respectively and for patients without distant metastases 62 and 50%. The importance of factors relating to prognosis was investigated with multivariate survival analysis. Metastases, nodal involvement and histological grade were strongly and independently associated with survival, but the influence of venous invasion was less important. When these factors are taken into consideration, direct extension, size and cell type of the tumour or sex and age of the patient give no significant additional prognostic information.

摘要

本文报告了连续257例接受根治性肾切除术治疗的肾癌患者。所有患者的5年和10年粗生存率分别为47%和31%,无远处转移患者的5年和10年粗生存率分别为62%和50%。通过多因素生存分析研究了与预后相关因素的重要性。转移、淋巴结受累和组织学分级与生存密切且独立相关,但静脉侵犯的影响相对较小。考虑这些因素后,肿瘤的直接蔓延、大小、细胞类型或患者的性别和年龄并未提供显著的额外预后信息。

相似文献

1
Prognostic factors in renal carcinoma. An evaluation of operative findings.肾癌的预后因素。手术所见的评估。
Br J Urol. 1984 Jun;56(3):270-5. doi: 10.1111/j.1464-410x.1984.tb05385.x.
2
Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.肾静脉及下腔静脉受累在肾细胞癌中的预后价值
Eur Urol. 2009 Feb;55(2):452-9. doi: 10.1016/j.eururo.2008.07.053. Epub 2008 Aug 5.
3
Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.pT3a期透明细胞肾细胞癌中的肾窦脂肪浸润影响无淋巴结受累或远处转移患者的预后。
J Urol. 2009 May;181(5):2027-32. doi: 10.1016/j.juro.2009.01.048. Epub 2009 Mar 14.
4
Prognostic factor for Korean patients with renal cell carcinoma and venous tumor thrombus extension: application of the new 2009 TNM staging system.韩国肾细胞癌伴静脉瘤栓患者的预后因素:新 2009 年 TNM 分期系统的应用。
Int Braz J Urol. 2013 May-Jun;39(3):353-63. doi: 10.1590/S1677-5538.IBJU.2013.03.08.
5
Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.肾外肿瘤扩展的位置不影响pT3a期肾细胞癌患者的生存率。
J Urol. 2007 Nov;178(5):1878-82. doi: 10.1016/j.juro.2007.07.011. Epub 2007 Sep 17.
6
Results of radical nephrectomy with extensive lymphadenectomy for renal cell carcinoma.
J Urol. 1983 Oct;130(4):664-8. doi: 10.1016/s0022-5347(17)51391-9.
7
Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.微血管肿瘤浸润、肿瘤大小与富尔曼分级:肾细胞癌预后评估的病理三联征
J Urol. 2007 Aug;178(2):425-8; discussion 428. doi: 10.1016/j.juro.2007.03.128. Epub 2007 Jun 11.
8
Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors.肾细胞癌的根治性广泛手术:长期结果及预后因素
J Urol. 1990 Mar;143(3):468-73; discussion 473-4. doi: 10.1016/s0022-5347(17)39992-5.
9
Renal cell carcinoma: I. Clinical indicators of prognosis.肾细胞癌:I. 预后的临床指标
N Z Med J. 1986 Jul 23;99(806):531-3.
10
Clinical and oncological outcomes in Chinese patients with renal cell carcinoma and venous tumor thrombus extension: single-center experience.中国肾细胞癌伴静脉瘤栓延伸患者的临床和肿瘤学结局:单中心经验
World J Surg Oncol. 2015 Feb 4;13:14. doi: 10.1186/s12957-015-0448-2.

引用本文的文献

1
Combined use of COX-1 and VEGF immunohistochemistry refines the histopathologic prognosis of renal cell carcinoma.COX - 1与VEGF免疫组化联合应用可优化肾细胞癌的组织病理学预后。
Int J Clin Exp Pathol. 2015 Jul 1;8(7):8165-77. eCollection 2015.
2
Renal cell carcinoma: risk assessment and prognostic factors for newly diagnosed patients.肾细胞癌:新诊断患者的风险评估与预后因素
Crit Rev Oncol Hematol. 2009 Apr;70(1):59-70. doi: 10.1016/j.critrevonc.2008.08.006. Epub 2008 Nov 6.
3
Comparison of chromosomal aberrations detected by fluorescence in situ hybridization with clinical parameters, DNA ploidy and Ki 67 expression in renal cell carcinoma.
荧光原位杂交检测的肾细胞癌染色体畸变与临床参数、DNA倍体及Ki 67表达的比较
Br J Cancer. 1998 Jun;77(11):2003-7. doi: 10.1038/bjc.1998.332.
4
Expression of histocompatibility antigens and characterisation of mononuclear cell infiltrates in human renal cell carcinomas.人肾细胞癌中组织相容性抗原的表达及单核细胞浸润的特征分析
Br J Cancer. 1987 Oct;56(4):433-7. doi: 10.1038/bjc.1987.219.
5
Acridine orange flow cytometric analysis of renal cell carcinoma. Clinicopathologic implications of RNA content.肾细胞癌的吖啶橙流式细胞术分析。RNA含量的临床病理意义。
Am J Pathol. 1990 Aug;137(2):275-80.